Source:http://linkedlifedata.com/resource/pubmed/id/19333141
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2009-11-16
|
pubmed:abstractText |
In severely injured and hypoperfused trauma patients, endogenous acute coagulopathy (EAC) is associated with an increased morbidity and mortality. Recent human data correlate this coagulopathy with activation of the protein C pathway. To examine the mechanistic role of protein C in the development of EAC, we used a mouse model of trauma and hemorrhagic shock, characterized by the combination of tissue injury and severe metabolic acidosis. Mice were subjected to one of four treatment groups: 1) C, control; 2) T, trauma (laparotomy); 3) H, hemorrhage (MAP, 35 mmHg x 60 min); 4) TH, trauma + hemorrhage. After 60 min, blood was drawn for analysis. Compared with C mice, the TH mice had a significantly elevated activated partial thromboplastin time (23.3 vs. 34.5 s) and significantly increased levels of activated protein C (aPC; 2.30 vs. 13.58 ng/mL). In contrast, T and H mice did not develop an elevated activated partial thromboplastin time or increased aPC. Selective inhibition of the anticoagulant property of aPC prevented the coagulopathy seen in response to trauma/hemorrhage (23.5 vs. 38.6 s [inhibitory vs. control monoclonal antibody]) with no impact on survival during the shock period. However, complete blockade of both the anticoagulant and cytoprotective functions of aPC caused 100% mortality within 45 min of shock, with histopathology evidence of pulmonary thrombosis and perivascular hemorrhage. These results indicate that our unique mouse model of T/H shock mimics our previous observations in trauma patients and demonstrates that EAC is mediated by the activation of the protein C pathway. In addition, the cytoprotective effect of protein C activation seems to be necessary for survival of the initial shock injury.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1540-0514
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
659-65
|
pubmed:meshHeading |
pubmed-meshheading:19333141-Acute Disease,
pubmed-meshheading:19333141-Animals,
pubmed-meshheading:19333141-Anticoagulants,
pubmed-meshheading:19333141-Blood Coagulation Disorders,
pubmed-meshheading:19333141-Male,
pubmed-meshheading:19333141-Mice,
pubmed-meshheading:19333141-Mice, Inbred C57BL,
pubmed-meshheading:19333141-Perfusion,
pubmed-meshheading:19333141-Protein C,
pubmed-meshheading:19333141-Pulmonary Circulation,
pubmed-meshheading:19333141-Shock, Hemorrhagic,
pubmed-meshheading:19333141-Time Factors,
pubmed-meshheading:19333141-Treatment Outcome,
pubmed-meshheading:19333141-Wounds and Injuries
|
pubmed:year |
2009
|
pubmed:articleTitle |
Increase in activated protein C mediates acute traumatic coagulopathy in mice.
|
pubmed:affiliation |
The Department of Surgery, University of California, San Francisco, California, USA. hermanodequeso@yahoo.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|